Abstract
Background
The low pO 2 in traumatic and septic shock was first documented at Walter Reed Army Medical Center starting in 1960. It was postulated that this respiratory failure was due to the occlusion of the pulmonary microcirculation by the microclots of disseminated intravascular coagulation (DIC).
Materials and Methods
Animal studies showed that pulmonary failure and death could be caused by intravenous injection of a killed culture of either Escherichia coli or pneumococcal organisms or by severe muscle contusion. Severe clinical septic and traumatic shock cases were studied.
Results
Injection of either killed E. coli or killed pneumococci resulted in acute respiratory distress syndrome (ARDS) and death in pigs. Muscle contusion also resulted in ARDS and death in pigs. Both ARDS and death were prevented by administration of a plasminogen activator, and ARDS in human septic or traumatic shock were safely and effectively treated by administration of a plasminogen activator.
Conclusions
Acute respiratory distress syndrome can be caused by DIC, which blocks the microcirculation of any and all organs. These microclots can be safely lysed by a plasminogen activator, thus treating ARDS and saving lives.
Similar content being viewed by others
References
The Medical Department of the United States Army in the World War. Surgery 1927;2:185
Hardaway RM. Disseminated intravascular coagulation syndrome. Arch Surg 1961;83:842–850
Hardaway RM. Syndromes of Disseminated Intravascular Coagulation with Special Reference to Shock and Hemorrhage. Springfield, IL, Charles C Thomas Publisher, 1966
Hardaway RM. Pulmonary microthrombi (presented at symposium on pulmonary embolic disease, Boston, MA, 22 May 1964). In Sasahara AA, ed, Pulmonary Embolic Disease, New York, Bruce-Shatton, 1965:65–72
Hardaway RM, James PM, Anderson RW, et al. Intensive study and treatment of shock in man. JAMA 1967;199:779–790
Hardaway RM. Shock lung. Int Surg 1973;58:311–315
Hardaway RM. Care of the Wounded in Viet Nam, Manhattan, KS, Sunflower University Press, 1988:139–221
Collins JA, Gordon WC Jr, Hudson TL, et al. Inapparent hypoxemia in casualties with wounded limbs. Ann Surg 1968;167:511–520
Bredenberg CE, James PM, Collins J, et al. Respiratory failure in shock. Ann Surg 1969;169:220
Collins JA. The cause of progressive pulmonary insufficiency in surgical patients. J Surg Res 1969:9
Martin AM, Simmons RL, Heisterkamp CA 3rd, et al. Respiratory insufficiency in combat casualties. I. Pathologic changes in the lungs of patients dying of wounds. Ann Surg 1969;170:30–38
Simmons RL, Martin AM, Heisterkamp CA 3rd, et al. Respiratory insufficiency in combat casualties. II. Pulmonary edema following head injury. Ann Surg 1969;170:39–44
Simmons RL, Heisterkamp CA 3rd, Martin AM, et al. Respiratory insufficiency in combat casualties. III. Arterial hypoxemia after wounding. Ann Surg 1969;170:45–52
Simmons RL, Heisterkamp CA 3rd, Collins JA, et al. Acute pulmonary edema in battle casualties. J Trauma 1969;9:760–775
Chiu D, Lubin B, Shohet SB. Erythrocyte membrane lipid reorganization during the sickling process. Br J Hematol 1974;41:223–234
Feola M, Simoni J, Cnizaro PC, et al. Toxicity of polymerized hemoglobin solutions. Surg Gynecol Obstet 1988;166:211–222
Ashbaugh DG, Bigelow DB, Petty TL, et al. Acute respiratory distress in adults. Lancet 1967:319–323
Ashbaugh DG, Petty TL, Bigelow DB, et al. Continuous positive pressure breathing in ARDS. J Thorac Cardiovasc Surg 1969:57
Warren HS. Strategies for the treatment of sepsis. N Engl J Med 1997;336:952–953
Zeni F, Freeman BF, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock, a reassessment. Crit Care Med 1997;25:1095–1100
Natanson C, Hoffman WD, Suffredini AF. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771–783
Fein AM, Calalang-Colucci MG. Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 2000;16:289–317
Baue AE. MOF, MODS, SIRS: Why no magic bullets? Arch Surg 1997;132:703–707
U.S. Department of Commerce Bureau of Census Statistical Abstract of the United States 1995
Balk RA. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit Care Clin 2000;16:337–352
Bernard GR, Vincent VL, Laterre PF. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709
Hardaway RM, Williams CH, Vasquez Y. Disseminated intravascular coagulation in sepsis. Semin Thrombosis Hemost 2001;27:577–583
Hardaway RM, Vasquez Y. A shock toxin that produces disseminated intravascular coagulation and multiple organ failure. Am J Med Sci 2001;322:222–228
Hardaway RM. A review of septic shock. Am Surg 2000;66:22–29
Gando S, Nanzaki S, Morimoto Y, et al. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma 1999;47:719–723
Gando S, Kamene T, Nanzaki S, et al. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 1997;25:1820–1826
Gando S, Kamene T, Morimoto Y, et al. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med 2001;8:1729–1734
Gando S, Kamene T, Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thrombohemostasis 2002;88:943–949
Gando S, Nanzaki S, Kemmotsu. Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunction after trauma. Ann Surg 1999;229:121–127
Gando S, Kamene T, Nanzaki S, et al. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thrombohemostasis 1996;75:224–228
Gando S, Nanzaki S, Aoi K, et al. Activation of the extrinsic coagulation pathway in patients with sepsis and septic shock. Crit Care Med 1998;26:2005–2009
Oberhofer D, Kueisee-Tepes N, et al. Coagulation tests in septic shock patients. Acta Med Croatia 2004;58:389–394
Hardaway RM, Williams CH, Marvasti M, et al. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Crit Care Med 1990;18:1413–1418
Hardaway RM, Burns VW. Mechanism of action of fibrinolysin in the prevention of “irreversible” hemorrhagic shock. Ann Surg 1963;157:305–309
Hardaway RM. Traumatic and septic shock alias post-trauma critical illness. Br J Surg 1998;85:1473–1479
Hardaway RM, Harke H, Tyroch A. Treatment of acute respiratory distress syndrome: a final report on a Phase I study. Am Surg 2001;67:377–382
Hardaway RM. Traumatic shock. Mil Med 2006:171
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hardaway, R.M. A Brief Overview of Acute Respiratory Distress Syndrome. World J. Surg. 30, 1829–1834 (2006). https://doi.org/10.1007/s00268-006-0030-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-006-0030-8